13 results on '"Beuzen F"'
Search Results
2. Chromosomal numerical aberrations are frequent in oesophageal and gastric adenocarcinomas: a study using in-situ hybridization
- Author
-
Beuzen, F, Dubois, S, and Fléjou, J-F
- Published
- 2000
3. 720 The diagnostic value of biomarkers (Ash Test) for the prediction of alcoholic steatohepatitis in patients with chronic alcoholic liver disease
- Author
-
Thabut, D., Naveau, S., Charlotte, F., Massard, J., Ratziu, V., Imbert-Bismuth, E., Cazals-Hatem, D., Abella, A., Messous, D., Beuzen, F., Munteanu, M., Taieb, J., Moreau, R., Lebrec, D., and Poynard, T.
- Published
- 2006
- Full Text
- View/download PDF
4. [An exceptional and misleading case of choledochal cyst].
- Author
-
Carloni A, Dagher I, Beuzen F, Dumas-De La Roque A, and Franco D
- Subjects
- Adult, Anastomosis, Roux-en-Y, Choledochal Cyst pathology, Choledochal Cyst surgery, Diagnosis, Differential, Echinococcosis diagnosis, Echinococcosis surgery, Female, Humans, Choledochal Cyst diagnosis
- Abstract
The authors report a case of choledocal cyst extended to left and right hepatic ducts. An heterogeneous intracystic fluid, partial calcification of cystic wall, a slight positivity of echinoccosis serology in a patient from a highly endemic country erroneously led to diagnosis of hydatid cyst invading the left hepatic duct. The diagnosis of choledocal cyst was done on the resection specimen after left hepatectomy. A small patch of cyst wall with terminations of both right sectorial hepatic ducts was used for cysto-jejunal Roux-en-Y loop anastomosis. Peculiarities of this type of choledocal cyst are discussed.
- Published
- 2006
- Full Text
- View/download PDF
5. Serum leptin in patients with alcoholic liver disease.
- Author
-
Naveau S, Perlemuter G, Chaillet M, Raynard B, Balian A, Beuzen F, Portier A, Galanaud P, Emilie D, and Chaput JC
- Subjects
- Adult, Chi-Square Distribution, Female, Humans, Liver Diseases, Alcoholic pathology, Logistic Models, Male, Middle Aged, Overweight physiology, Prospective Studies, Risk Factors, Leptin blood, Liver Diseases, Alcoholic blood
- Abstract
Background: The mechanisms by which overweight makes the liver more susceptible to alcoholic liver injury remain to be determined. Therefore, we conducted the following studies to further elucidate the role of leptin in the pathogenesis of steatosis and cirrhosis caused by chronic alcohol consumption in human beings., Methods: Two-hundred nine consecutive patients with alcoholic liver disease were studied. Serum leptin concentrations were measured by using radioimmunoassay, and the relationships between serum leptin level and liver lesions were studied. Statistical analysis used logistic regressions., Results: When serum leptin, serum cholesterol, and body mass index (BMI) were considered together in the multiple logistic regression analysis, compared with patients with severe steatosis, serum leptin remains significantly lower in patients without steatosis (p<0.05) and in patients with mild or moderate steatosis (p<0.05). When age, serum leptin, serum cholesterol, and steatosis grade were considered together in the logistic regression analysis, serum leptin (p<0.01) and age (p<0.02) were positively and independently correlated with the presence of cirrhosis. After BMI introduction in the statistical model, serum leptin was no more correlated with the presence of cirrhosis., Conclusion: In patients with alcoholic liver disease, serum leptin is independently correlated with steatosis grade and might play an important role in severity of fibrosis as fatty liver is more vulnerable than normal liver to factors that lead to fibrosis.
- Published
- 2006
- Full Text
- View/download PDF
6. The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease.
- Author
-
Thabut D, Naveau S, Charlotte F, Massard J, Ratziu V, Imbert-Bismut F, Cazals-Hatem D, Abella A, Messous D, Beuzen F, Munteanu M, Taieb J, Moreau R, Lebrec D, and Poynard T
- Subjects
- Adult, Biomarkers analysis, Chronic Disease, Fatty Liver, Alcoholic pathology, Female, Hepatitis, Alcoholic pathology, Humans, Male, Middle Aged, Prognosis, Reproducibility of Results, Fatty Liver, Alcoholic diagnosis, Hepatitis, Alcoholic diagnosis
- Abstract
Background/aims: The aim was to identify a panel of biomarkers (AshTest) for the diagnosis of alcoholic steato-hepatitis (ASH), in patients with chronic alcoholic liver disease., Methods: Biomarkers were assessed in patients with an alcohol intake>50 g/d, in a training group, and in two validation groups. Diagnosis of ASH (polymorphonuclear infiltrate and hepatocellular necrosis) and its histological severity (four classes: none, mild, moderate and severe) were assessed blindly., Results: Two hundred and twenty-five patients were included, 70 in the training group, 155 in the validation groups, and 299 controls. AshTest was constructed using a combination of the six components of FibroTest-ActiTest plus aspartate aminotransferase. The AshTest area under the ROC curves for moderate-severe ASH was 0.90 in the training group, 0.88 and 0.89 in the validation groups. The median AshTest value was 0.005 in controls, 0.05 in patients without or with mild ASH, 0.64 in moderate, and 0.84 in severe ASH grade 3, (P<0.05 between all groups). At a 0.50 cut-off, the sensitivity of AshTest was 0.80 and the specificity was 0.84., Conclusions: In heavy drinkers, AshTest is a simple and non-invasive quantitative estimate of alcoholic hepatitis. The use of AshTest may reduce the need for liver biopsy, and therefore allow an earlier treatment of alcoholic hepatitis.
- Published
- 2006
- Full Text
- View/download PDF
7. Bronchoalveolar lavage cytological alveolar damage in patients with severe pneumonia.
- Author
-
Grigoriu B, Jacobs F, Beuzen F, El Khoury R, Axler O, Brivet FG, and Capron F
- Subjects
- Community-Acquired Infections pathology, Hemorrhage diagnosis, Humans, Pneumonia classification, Prospective Studies, Reproducibility of Results, Bronchoalveolar Lavage Fluid cytology, Cross Infection pathology, Lung pathology, Pneumonia pathology
- Abstract
Introduction: Histological examination of lung specimens from patients with pneumonia shows the presence of desquamated pneumocytes and erythrophages. We hypothesized that these modifications should also be present in bronchoalveolar lavage fluid (BAL) from patients with hospital-acquired pneumonia., Methods: We conducted a prospective study in mechanically ventilated patients with clinical suspicion of pneumonia. Patients were classified as having hospital-acquired pneumonia or not, in accordance with the quantitative microbiological cultures of respiratory tract specimens. A group of severe community-acquired pneumonias requiring mechanical ventilation during the same period was used for comparison. A specimen of BAL (20 ml) was taken for cytological analysis. A semiquantitative analysis of the dominant leukocyte population, the presence of erythrophages/siderophages and desquamated type II pneumocytes was performed., Results: In patients with confirmed hospital-acquired pneumonia, we found that 13 out of 39 patients (33.3%) had erythrophages/siderophages in BAL, 18 (46.2%) had desquamated pneumocytes and 8 (20.5%) fulfilled both criteria. Among the patients with community-acquired pneumonia, 7 out of 15 (46.7%) had erythrophages/siderophages and 6 (40%) had desquamated pneumocytes on BAL cytology. Only four (26.7%) fulfilled both criteria. No patient without hospital-acquired pneumonia had erythrophages/siderophages and only 3 out of 18 (16.7%) had desquamated pneumocytes on BAL cytology., Conclusion: Cytological analysis of BAL from patients with pneumonia (either community-acquired or hospital-acquired) shows elements of cytological alveolar damage as hemorrhage and desquamated type II pneumocytes much more frequently than in BAL from patients without pneumonia. These elements had a high specificity for an infectious cause of pulmonary infiltrates but low specificity. These lesions could serve as an adjunct to diagnosis in patients suspected of having ventilator-associated pneumonia.
- Published
- 2006
- Full Text
- View/download PDF
8. Fetal type IV glycogen storage disease: clinical, enzymatic, and genetic data of a pure muscular form with variable and early antenatal manifestations in the same family.
- Author
-
L'herminé-Coulomb A, Beuzen F, Bouvier R, Rolland MO, Froissart R, Menez F, Audibert F, and Labrune P
- Subjects
- Adult, Female, Fetal Death, Fetal Diseases enzymology, Fetal Diseases genetics, Glycogen Storage Disease Type IV enzymology, Glycogen Storage Disease Type IV genetics, Humans, Male, Pregnancy, Fetal Diseases physiopathology, Glycogen Storage Disease Type IV physiopathology
- Abstract
We report on a family of three consecutive fetuses affected by type IV glycogen storage disease (GSD IV). In all cases, cervical cystic hygroma was observed on the 12-week-ultrasound examination. During the second trimester, fetal hydrops developed in the first pregnancy whereas fetal akinesia appeared in the second pregnancy. The diagnosis was suggested by microscopic examination of fetal tissues showing characteristic inclusions exclusively in striated fibers, then confirmed by enzymatic studies on frozen muscle. Antenatal diagnosis was performed on the third and fourth pregnancies: cervical cystic hygroma and low glycogen branching enzyme (GBE) activity on chorionic villi sample (CVS) were detected in the third pregnancy whereas ultrasound findings were normal and GBE activity within normal range on CVS in the fourth pregnancy. Molecular analysis showed that the mother was heterozygous for a c.1471G > C mutation in exon 12, leading to the replacement of an alanine by a tyrosine at codon 491 (p.A491T); the father was heterozygous for a c.895G > T mutation in exon 7, leading to the creation of a stop codon at position 299 (p.G299X). GSD IV has to be considered in a context of cervical cystic hygroma with normal karyotype, particularly when second trimester hydrops or akinesia develop. Enzymatic analysis of GBE must be performed on CVS or amniotic cells to confirm the diagnosis. Characteristic intracellular inclusions are specific to the disease and should be recognized, even in macerated tissues after fetal death. Genetic analysis of the GBE gene may help to shed some light on the puzzling diversity of GSD IV phenotypes., (Copyright 2005 Wiley-Liss, Inc.)
- Published
- 2005
- Full Text
- View/download PDF
9. Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease.
- Author
-
Naveau S, Raynard B, Ratziu V, Abella A, Imbert-Bismut F, Messous D, Beuzen F, Capron F, Thabut D, Munteanu M, Chaput JC, and Poynard T
- Subjects
- Biopsy, Needle, Chronic Disease, Disease Progression, Female, Humans, Immunohistochemistry, Liver Function Tests, Male, Middle Aged, Predictive Value of Tests, Probability, Prognosis, Prospective Studies, Risk Assessment, Sensitivity and Specificity, Severity of Illness Index, Statistics, Nonparametric, Survival Analysis, Biomarkers blood, Hyaluronic Acid blood, Liver Cirrhosis mortality, Liver Cirrhosis pathology, Liver Diseases, Alcoholic mortality, Liver Diseases, Alcoholic pathology
- Abstract
Background & Aims: The aim of this study was to determine the diagnostic use of noninvasive markers of fibrosis in patients with chronic alcoholic liver disease., Methods: A total of 221 consecutive patients with an alcohol intake of >50 g/day (median, 100 g/day) and available liver biopsy examination and FibroTest FibroSure (FT) results were included prospectively. Fibrosis was assessed blindly on a 5-stage histologic scale similar to that of the METAVIR scoring system. Hyaluronic acid was measured and used as a standard serum marker of fibrosis., Results: Advanced fibrosis (F2-F4) was present at biopsy examination in 63% of patients. The mean FT value (SE) was F0 = .29 (.05); F1 = .29 (.03), F2 = .40 (.03), F3 = .53 (.04); and F4 = .88 (.02) (P < .05 between all groups, except between F0 and F1). As opposed to FT, there was no significant difference for hyaluronic acid between F2 and F1 and between F2 and F0. For F2-F4 vs. F0-F1, the FT area under the ROC curves (AUROC) = .84 (.03) and .79 (.03) for hyaluronic acid. For the diagnosis of F4, the AUROC was very high, .95 for FT and .93 for hyaluronic acid. The discordances of the 2 stages were attributed to biopsy failures in 26 cases and to FT failures in 13 cases., Conclusions: In heavy drinkers, FT is a simple and noninvasive quantitative estimate of liver fibrosis. The use of FT may decrease the need for liver biopsy examination.
- Published
- 2005
- Full Text
- View/download PDF
10. [Primary leiomyoma of the liver: a rare benign tumor].
- Author
-
Beuzen F, Roudie J, Moali I, Maitre S, Barthelemy P, and Smadja C
- Subjects
- Adult, Female, Humans, Leiomyoma diagnosis, Liver Neoplasms diagnosis
- Abstract
Primary hepatic leiomyoma is a very rare tumor secondary to benign smooth muscle proliferation. The primary location in the liver is usually found in adult women. A 36-year-old woman with right upper quadrant abdominal pain had primary hepatic leiomyoma. The presenting features of primary leiomyoma and the diagnostic approach for these lesions are discussed, in particular the role of immunohistochemistry.
- Published
- 2004
- Full Text
- View/download PDF
11. [Suppurated hepatic metastasis revealing a colonic stromal tumor].
- Author
-
Ratel-Saby S, Ah-Hot P, Ratouis A, Beuzen F, Landau A, Franco D, Petite JP, Bruneval P, and Bloch F
- Subjects
- Humans, Immunohistochemistry, Liver Neoplasms diagnostic imaging, Male, Middle Aged, Proto-Oncogene Proteins c-kit analysis, Radionuclide Imaging, Colonic Neoplasms diagnosis, Liver Neoplasms secondary
- Published
- 2001
12. [Ulceronecrotic tracheobronchial involvement in Crohn's disease].
- Author
-
Montembault S, Le Gall C, Balian A, Beuzen F, Naveau S, Capron F, and Chaput JC
- Subjects
- Adolescent, Anti-Inflammatory Agents therapeutic use, Biopsy, Bronchial Diseases pathology, Chronic Disease, Crohn Disease diagnosis, Crohn Disease drug therapy, Female, Humans, Necrosis, Steroids, Tracheal Diseases pathology, Ulcer pathology, Bronchial Diseases etiology, Cough etiology, Crohn Disease complications, Tracheal Diseases etiology, Ulcer etiology
- Abstract
We report the case of a young female patient hospitalized for the first episode of a colonic Crohn's disease with specific ulceronecrotic tracheobronchial involvement leading to chronic and invalidant cough. Symptomatic bronchopulmonary manifestations are very rare in the course of inflammatory bowel diseases and usually not mentioned in Gastroenterology textbooks.
- Published
- 2001
13. [Ovarian endometriosis cyst with iodine 131 uptake : first case of false positive in the follow up for differentiated thyroid carcinoma].
- Author
-
Lungo M, Tenenbaum F, Chaumerliac P, Vons C, Mirat A, Beuzen F, Luton JP, and Richard B
- Subjects
- Adult, False Positive Reactions, Female, Humans, Radionuclide Imaging, Carcinoma, Papillary diagnostic imaging, Endometriosis diagnostic imaging, Iodine Radioisotopes, Ovarian Cysts diagnostic imaging, Thyroid Neoplasms diagnostic imaging
- Abstract
A whole body scan is performed after a radioiodine treatment in patients with differentiated thyroid carcinoma. This scan is useful coupled with thyroglobulin level for the patient's management. When unusual uptake is found, investigations have to be done to eliminate thyroid metastasis. A 28-year old woman underwent a total thyroidectomy for micro papillary carcinoma. Two years and a half after, ultrasonography of the neck showed a small lymph node in homolateral side of carcinoma. It was decided to begin treatment with iodine 131. The post-therapeutic scan showed an abnormal pelvic uptake. IRM found no osseous abnormality but an ovarian lesion. After surgery, histological diagnosis was an endometriosis cyst without thyroid or tumoral cells. Abdominal ou pelvic iodine false positive are rare. Ovarian cysts may be the cause of false positive radioiodine uptake. Endometriosis cyst was not previously described and the mecanism of iodine uptake is not clear.
- Published
- 2000
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.